Literature DB >> 17416781

Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.

Philip E Castle1, Mark Sadorra, Francisco A R Garcia, Allison P Cullen, Attila T Lorincz, Amy L Mitchell, Denise Whitby, Ronald Chuke, Janet R Kornegay.   

Abstract

The usefulness of mouthwash as a transport medium for cervical specimens for carcinogenic human papillomavirus (HPV) DNA testing has not been evaluated. Two cervical specimens were collected from each of 34 patients, with one placed in mouthwash (Scope, Proctor and Gamble, Inc.) and the other in a liquid cytology medium commonly used for HPV DNA testing in alternating order. Paired specimens were tested by a PCR assay for carcinogenic HPV and a PCR HPV genotyping assay for 37 HPV types at 0, 3, and 6 weeks after collection; the results of the HPV genotyping assay were categorized into HPV risk groups according to cancer risk (HPV-16 > HPV-18 > other carcinogenic HPV types > noncarcinogenic HPV types > negative). After 4 months of storage, specimens were tested using a second, non-PCR test for carcinogenic HPV. We observed a >or=94% total agreement and kappa values of >or=0.88 between media at each time point for PCR-detected carcinogenic HPV. We observed a >or=74% total agreement, >or=0.62 unweighted kappa, and >or=0.75 linearly weighted kappa between media at each time point for PCR-detected HPV cancer risk category. Finally, we observed an 88% total agreement and kappa of 0.77 between media for carcinogenic HPV detection using a second test after 4 months of storage. We suggest that mouthwash might be used as a low-cost, safe, nonflammable storage and transport medium for cervical specimens for HPV DNA testing in cervical cancer screening programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416781     DOI: 10.1158/1055-9965.EPI-06-0909

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Comparative community outreach to increase cervical cancer screening in the Mississippi Delta.

Authors:  Philip E Castle; Alfio Rausa; Tameka Walls; Patti E Gravitt; Edward E Partridge; Vanessa Olivo; Shelley Niwa; Kerry Grace Morrissey; Laura Tucker; Hormuzd Katki; Isabel Scarinci
Journal:  Prev Med       Date:  2011-04-08       Impact factor: 4.018

2.  Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States.

Authors:  Jennifer S Smith; Andrea C Des Marais; Allison M Deal; Alice R Richman; Carolina Perez-Heydrich; Belinda Yen-Lieberman; Lynn Barclay; Jerome Belinson; Allen Rinas; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2018-01       Impact factor: 2.830

3.  Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.

Authors:  Isabel C Scarinci; Allison G Litton; Isabel C Garcés-Palacio; Edward E Partridge; Philip E Castle
Journal:  Womens Health Issues       Date:  2013-02-12

4.  Comparative performance of human papillomavirus DNA testing using novel sample collection methods.

Authors:  Julia C Gage; Edward E Partridge; Alfio Rausa; Patti E Gravitt; Sholom Wacholder; Mark Schiffman; Isabel Scarinci; Philip E Castle
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

5.  Acceptability and ease of use of mailed HPV self-collection among infrequently screened women in North Carolina.

Authors:  Chelsea Anderson; Lindsay Breithaupt; Andrea Des Marais; Charlotte Rastas; Alice Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2017-09-02       Impact factor: 3.519

6.  Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.

Authors:  Pedro Surriabre; Gustavo Allende; Marcela Prado; Leyddy Cáceres; Diego Bellot; Andrea Torrico; Karina Ustariz; Shirley Rojas; Jaime Barriga; Pamela Calle; Ligia Villarroel; Rosse Mary Yañez; Marc Baay; Patricia Rodriguez; Véronique Fontaine
Journal:  BMC Womens Health       Date:  2017-12-22       Impact factor: 2.809

7.  The feasibility of new HPV/DNA test as a primary cervical cancer screening method among 35- years- old ever-married women in Kalutara district; a cross-sectional study.

Authors:  K C M Perera; N Mapitigama; Htcs Abeysena
Journal:  BMC Public Health       Date:  2021-01-13       Impact factor: 3.295

8.  Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.

Authors:  Philip E Castle; Julia C Gage; Edward E Partridge; Alfio Rausa; Patti E Gravitt; Isabel C Scarinci
Journal:  BMC Infect Dis       Date:  2013-01-07       Impact factor: 3.090

9.  Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Authors:  Hong Lou; Eduardo Gharzouzi; Sarita Polo Guerra; Joël Fokom Domgue; Julie Sawitzke; Guillermo Villagran; Lisa Garland; Joseph F Boland; Sarah Wagner; Héctor Rosas; Jami Troxler; Heidi McMillen; Bailey Kessing; Enrique Alvirez; Miriam Castillo; Hesler Morales; Victor Argueta; Andert Rosingh; Femke J H B van Aerde-van Nunen; Griselda Lopez; Herbert M Pinedo; Mark Schiffman; Michael Dean; Roberto Orozco
Journal:  BMC Cancer       Date:  2018-05-15       Impact factor: 4.430

10.  HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study.

Authors:  Audrey R Murchland; Anna Gottschlich; Kristin Bevilacqua; Andres Pineda; Berner Andrée Sandoval-Ramírez; Christian S Alvarez; Gina S Ogilvie; Thomas E Carey; Mark Prince; Michael Dean; Carlos Mendoza Montano; Alvaro Rivera-Andrade; Rafael Meza
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.